Castle Biosciences CSTL
NASDAQ CSTL
$33.19 -1.18 (-3.43%)
At close: Oct 22, 2026 · 4:00 PM EDT

Castle Biosciences (CSTL) Non-Current Deffered Revenue (2020 - 2021)

Updated

Castle Biosciences (CSTL) reported Non-Current Deffered Revenue of $172,000 for Q1 2021, down 90.1% from the prior quarter.

Analysis

Castle Biosciences (CSTL) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends

At the end of FY2020, Castle Biosciences posted Non-Current Deffered Revenue of $1.74 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 HCA Healthcare 102.67 Bn 98.68 Bn - -
2 Natera 57.42 Bn 53.11 Bn 485.19 Mn 16.07 Mn
3 Quest Diagnostics 27.06 Bn 25.19 Bn 1.03 Bn -
4 Labcorp Holdings 26.94 Bn 24.68 Bn 1.11 Bn -
5 Tenet Healthcare 22.62 Bn 11.62 Bn - -
6 Guardant Health 21.58 Bn 17.64 Bn 219.03 Mn -
7 Fresenius Medical Care AG 12.91 Bn 4.86 Bn 1.52 Bn -
8 BrightSpring Health Services 12.52 Bn 10.85 Bn 492.75 Mn -
9 Encompass Health 12.42 Bn 12.08 Bn - -
10 Castle Biosciences 1.01 Bn -106.40 Mn 79.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 172,000.00
Dec 31, 2020 1.74 Mn
API Access

Castle Biosciences Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CSTL&period=max&api_key=YOUR_API_KEY